ASV Therapy for Insomnia

Part of paid clinical trials in Detroit, Michigan.

Sponsor
ResMed
Study ID
NCT07011966
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • ASV therapy — DEVICE
    Adaptive servo ventilation (ASV) therapy using ResMed AirCurve 11 device will be used to target potential upper airway resistance and respiratory related arousals in patients with insomnia. The ASV device is approved for the treatment of obstructive sleep apnea, and this will be designated as the investigational device for this study with appropriate labelling.

Study Details

This will be a single center, prospective study designed to evaluate the effect of adaptive servo ventilation therapy on insomnia severity among patients with moderate to severe chronic insomnia.

Key Dates

Start date
Mar 1, 2026
Status verified
May 2026
Primary completion
Dec 31, 2026
Completion
Feb 28, 2027

Study Design

Enrollment
25 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: ASV Therapy

Primary Outcome Measure

Insomnia Severity Index (ISI) score [ Time Frame: 4 weeks after therapy start ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
C.S. Mott CenterDetroitMichigan48201
Karen Collins
[email protected]
313-577-8606

Find similar trials in Detroit, MI

By condition
Insomnia
By specialty
Mental healthSleep medicine
By research site
C.S. Mott Center· Detroit, MI

Related Studies